Crystal structure of a novel heterooligomeric aminotransferase from Serratia sp. ATCC 39006 provides insights into function

Heru Pramono,Ayako Yoshida,Yuki Hirashima,Yusuke Sone,Tohru Terada,Saori Kosono,Makoto Nishiyama
DOI: https://doi.org/10.1002/1873-3468.15068
2024-12-03
FEBS Letters
Abstract:Serratia sp. ATCC 39006 has two aminotransferase genes, ser4 and ser5, in a putative secondary metabolite gene cluster that includes a gene encoding an amino‐group carrier protein (AmCP). Here, we determined the crystal structures of the heterotetramer complex of Ser4 and Ser5 (SerTA). Biochemical and in silico analysis revealed that heterotetramer formation is crucial for its activity. Serratia sp. ATCC 39006 has two tandemly positioned genes, ser4 and ser5, both annotated as sugar aminotransferases, in a putative secondary metabolite biosynthetic gene cluster. Ser5 possesses a complete fold‐type I aminotransferase fold, while Ser4 lacks the N‐ and C‐terminal regions and a catalytically important lysine residue of fold‐type I aminotransferase. We herein revealed that Ser4 and Ser5 formed a heterotetrameric complex (SerTA) with aminotransferase activity and determined the crystal structures. MD simulations and activity assays with SerTA variants indicated that residues from helix α‐8* of inactive Ser4 are important for activity, confirming the importance of heterocomplex formation for activity. Furthermore, the structures suggest that SerTA recognizes a substrate loaded on the carrier protein.
cell biology,biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?